Skip to main content

Freitag Gregory Gene

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Freitag Gregory Gene as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

PDSB PDS Biotechnology Corp

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 3, 2025 (view filing)Feb 283 daysFreitag Gregory GeneDirectorPPurchase+15.1K$1.66+$25.0K+32.6%61.2K after
Mar 3, 2025 (view filing)Feb 283 daysFreitag Gregory GeneDirectorPPurchase+15.1K–––15.1K afterDerivative

AXGN Axogen, Inc.

Director7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 8, 2024 (view filing)Mar 71 dayFreitag Gregory GeneDirectorSSale−25.0K$9.00−$225.0K−8.4%271.6K after
Jun 5, 2023 (view filing)Jun 14 daysFreitag Gregory GeneDirectorSSale−42.0K$8.71−$365.8K−12.6%290.1K after2 lots
May 24, 2023 (view filing)May 231 dayFreitag Gregory GeneDirectorSSale−7.47K$9.23−$68.9K−2.2%332.1K after2 lots
Nov 16, 2022 (view filing)Nov 142 daysFreitag Gregory GeneDirectorSSale−13.0K$12.74−$165.6K−3.7%339.6K after
Nov 10, 2022 (view filing)Nov 82 daysFreitag Gregory GeneDirectorSSale−13.0K$12.50−$162.5K−3.6%352.6K after
Aug 11, 2022 (view filing)Aug 101 dayFreitag Gregory GeneDirectorSSale−8.89K$9.70−$86.2K−2.4%365.6K after
Aug 8, 2022 (view filing)Aug 4-84 daysFreitag Gregory GeneDirectorSSale−37.0K$10.54−$390.6K−9.0%374.5K after2 lots